1158 Inorganic Chemistry, Vol. 50, No. 3, 2011
Schweinfurth et al.
126.0 (aryl-C), 126.9 (aryl-C), 127.4 (q, 3JC-F = 5 Hz, CF3-C-
CH), 133.0 (aryl-C), 134.7 (q, 3JC-F = 2 Hz, CF3-C-C-NHR),
147.0 (NHR-C-CdO), 157.9 (OH-C-CdO), 180.4
(OdC-C-NHR), 182.2 (OdC-C-OH). 19F{1H} NMR (235
MHz, CDCl3): δ -61.5.
3JH-H = 6.9 Hz, 3H, CH(CH3)2), 1.27 (d, 3JH-H = 6.9 Hz, 3H,
CH(CH3)2), 1.89 (s, 3H, CH3), 2.20 (s, 3H, CH3), 2.46 (sept,
3JH-H = 7.9 Hz, 1H, CH(CH3)2), 2.86 (sept, 3JH-H = 6.9 Hz,
1H, CH(CH3)2), 4.92 (s, 1H, quinone-H), 4.96 (d, 3JH-H = 5.9
Hz, 1H, arene-H), 5.25 (d, 3JH-H = 5.6 Hz, 1H, arene-H), 5.27
(d, 3JH-H = 5.6 Hz, 2H, arene-H), 5.40 (d, 3JH-H = 6.0 Hz, 2H,
2,5-Di-[2-(trifluoromethyl)-anilino]-1,4-benzoquinone (L2). The
compound was prepared following the procedure for L1 by using
2,5-dihydroxybenzoquinone (300 mg, 2.15 mmol) and two equiva-
lentsof 2-(trifluoromethyl)aniline (690 mg, 4.30 mmol). The crude
product was cleaned by column chromatography using silica and
CH2Cl2 as the eluent. After evaporation of the solvent, the
product was obtained as a red solid (682 mg, 73%). X-ray-quality
crystals could be grown by the slow diffusion of hexane into a
dichloromethane solution. Anal. Calcd for C20H12F6N2O2: C,
3
arene-H), 5.48 (d, JH-H = 4.6 Hz, 1H, arene-H), 5.50 (d,
3JH-H = 4.6 Hz, 1H, arene-H), 5.85 (s, 1H, quinone-H), 7.39 (t,
3
3JH-H = 7.9 Hz, 1H, aryl-H), 7.57 (t, JH-H = 6.9 Hz, 1H,
=
aryl-H), 7.67 (d, 3JH-H = 8.7 Hz, 1H, aryl-H), 7.71 (d, 3JH-H
8.3 Hz, 1H, aryl-H).
[{Cl(η6-Cym)Ru}2(μ-L-2H2)] (2). The compound was prepared
following the procedure for 1 by using Ru2(Cym)2Cl4 (80 mg,
0.13 mmol) and ligand L2 (55.4 mg, 0.13 mmol). The desired
product was obtained as a purple solid (114 mg, 91%). Crystals for
X-ray diffraction could be obtained from the slow evaporation of
a CH2Cl2 solution. Anal. Calcd for C40H38Cl2F6N2O2Ru2: C,
49.75; H, 3.97; N, 2.90. Found: C, 49.64; H, 3.86; N, 2.82. MS (ESI)
Calcd for C40H38ClF6N2O2Ru2 ([M - Cl-]þ) and C40H38F6-
N2O2Ru2 ([M - 2 Cl-]2þ): m/z 931.06 and 447.44. Found:
931.06 and 447.56. 1H NMR (250 MHz, CD2Cl2): δ 1.09 (d,
1
56.35; H, 2.84; N, 6.57. Found: C, 56.08; H, 2.83; N, 6.48. H
NMR (250 MHz, CDCl3): δ 5.87 (s, 2H, quinone-H), 7.36 (t,
3JH-H = 8 Hz, 2H, aryl-H), 7.50 (d, 3JH-H = 8.0 Hz, 2H, aryl-H),
7.62 (t, 3JH-H = 8.0 Hz, 2H, aryl-H), 7.73 (d, 3JH-H = 8 Hz, 2H,
aryl-H), 8.02 (s, 2H, NH). 13C{1H} NMR (62.9 MHz, CDCl3): δ
96.9 (OdC-C-C-NHR), 123.4 (q, 1JC-F = 273 Hz, CF3), 124.9
(q, 2JC-F = 30 Hz, CF3-C-CH)), 125.9 (aryl-C), 126.4 (aryl-C),
3
3
3JH-H = 7 Hz, 6H, CH(CH3)2), 1.16 (d, JH-H = 7 Hz, 6H,
127.4 (q, JC-F = 5 Hz, CF3-C-CH-CH)), 133.0 (aryl-C),
135.3 (q, 3JC-F = 2 Hz, CF3-C-C-NHR), 146.8 (NHR-C-
CdO), 180.3 (OdC-C-NHR). 19F{1H} NMR (235 MHz,
CDCl3): δ -61.5.
CH(CH3)2), 1.86 (s, 6H, CH3), 2.31 (sept, 3JH-H = 7.0 Hz, 1H,
CH(CH3)2), 2.40 (sept, 3JH-H = 7.0 Hz, 1H, CH(CH3)2), 4.89 (d,
3JH-H = 6.5 Hz, 2H, arene-H), 4.95 (s, 2H, quinone-H), 5.19 (d,
3
3JH-H = 6.0 Hz, 2H, arene-H), 5.31 (d, JH-H = 6.1 Hz, 4H,
2-[2-(Methylthio)-anilino]-5-hydroxy-1,4-benzoquinone (L3). The
compound was prepared following the procedure for L1 by using
2,5-dihydroxybenzoquinone (300 mg, 2.15 mmol) and one equiva-
lent of 2-(methylthio)aniline (299 mg, 2.15 mmol). The crude
product was cleaned by column chromatography using silica and
CH2Cl2/MeOH (10/1) as the eluent. After evaporation of the
solvent, the product was obtained as a red solid (332 mg, 51.5%).
Anal. Calcd for C13H11NO3S: C, 59.76; H, 4.24; N, 5.36. Found:
C, 59.28; H, 4.07; N, 5.33. 1H NMR (250 MHz, CDCl3): δ 2.06 (s,
3H, SCH3), 5.27 (s, 1H, quinone-H), 5.97 (s, 1H, quinine-H), 7.24
(m, 2H, aryl-H), 7.37 (m, 2H, aryl-H), 8.33 (s, 1H, NH). 13C{1H}
NMR (62.9 MHz, CDCl3): δ 16.6 (CH3-SR), 95.2 (OdC-
C-C-NHR), 103.3 (OH-C-C-CdO), 123.1 (aryl-C), 126.84
(aryl-C), 127.1 (aryl-C), 129.5 (aryl-C), 133.2 (aryl-C), 135.1
(NHR-C-C-S-CH3), 146.2 (OdC-C-NHR), 158.5 (OH-
C-CdO), 180.1 (OdC-C-NHR), 182.7 (OdC-C-OH).
2,5-Di-[2-(methylthio)-anilino]-1,4-benzoquinone (L4). The com-
pound was prepared following the procedure for L1 by using 2,
5-dihydroxybenzoquinone (300 mg, 2.15 mmol) and two equivalents
of 2-(methylthio)aniline (598 mg, 4.30 mmol). After the reaction, no
further purification was necessary, and the red compound could be
obtained after filtration (720 mg, 87%). Crystals for X-ray diffrac-
tion could be obtained from the slow evaporation of a CHCl3/
MeOH solution. Anal. Calcd for C20H18N2O2S2: C, 62.50; H, 4.74;
arene-H), 7.46 (t, 3JH-H = 7.4 Hz, 2H, aryl-H), 7.63 (t, 3JH-H
7.8 Hz, 2H, aryl-H), 7.74 (m, 4H, aryl-H).
=
[{Cl(η6-Cym)Ru}2(μ-L-2H3)] (3). The compound was pre-
pared following the procedure for 1 by using Ru2(Cym)2Cl4
(80 mg, 0.13 mmol) and ligand L3 (33.9 mg, 0.13 mmol). The
compound was obtained as a reddish-purple solid (96 mg, 92%).
Calcd for C33H37Cl2NO3SRu2: C, 49.50; H, 4.66; N, 1.75.
Found: C, 49.48; H, 4.60; N, 1.73. MS (ESI) Calcd for
C33H37ClNO3SRu2 ([M - Cl-]þ): m/z 766.02. Found: 766.00.
1H NMR (250 MHz, CDCl3): δ 1.08 (d, 3JH-H = 6.9 Hz, 3H,
CH(CH3)2), 1.16 (d, 3JH-H = 6.9 Hz, 3H, CH(CH3)2), 1.24 (d,
3JH-H = 1.9 Hz, 3H, CH(CH3)2), 1.27 (d, 3JH-H = 2.0 Hz, 3H,
CH(CH3)2), 2.20 (s, 3H, CH3), 2.41 (s, 3H, CH3), 2.53 (s, 3H,
SCH3), 2.85 (sept, 3JH-H = 6.9 Hz, 1H, CH(CH3)2), 3.70 (sept,
3JH-H = 2.6 Hz, 1H, CH(CH3)2), 5.03 (s, 1H, quinone-H), 5.06
(d, 3JH-H = 4.8 Hz, 1H, arene-H), 5.25 (d, 3JH-H = 5.8 Hz, 2H,
3
arene-H), 5.34 (d, JH-H = 5.7 Hz, 1H, arene-H), 5.47 (d,
3
3JH-H =5.2 Hz, 3H, arene-H), 5.58 (d, JH-H =5.4 Hz, 1H,
arene-H), 5.83 (s, 1H, quinone-H), 7.12 (m, 1H, aryl-H), 7.21 (m,
2H, aryl-H), 7.36 (m, 1H, aryl-H).
[{Cl(η6-Cym)Ru}2(μ-L-2H4)] (4). The compound was pre-
pared following the procedure for 1 by using Ru2(Cym)2Cl4
(80 mg, 0.13 mmol) and ligand L4 (49.8 mg, 0.13 mmol). The
compound was obtained as a purple solid (120 mg, 93%). X-ray-
quality crystals could be obtained by the slow diffusion of ether
into a CH3CN/MeOH solution. Anal. Calcd for C40H44Cl2N2-
O2Ru2S2 þ 1/2CH2Cl2: C, 50.44; H, 4.70; N, 2.90. Found: C,
50.33; H, 4.76; N, 3.14. HRMS (ESI) Calcd for C40H44N2O2-
Ru2S2 ([M - 2 Cl-]2þ): m/z 426.0470. Found: 426.0461. 1H
1
N, 7.32. Found: C, 62.44; H, 4.42; N, 7.30. H NMR (250 MHz,
CD2Cl2):δ2.45 (s, 6H, SCH3), 5.95 (s, 2H, quinone-H), 7.27 (m, 4H,
aryl-H), 7.43 (m, 4H, aryl-H), 8.30 (s, 2H, NH). 13C{1H} NMR
(62.9 MHz, CDCl3):δ16.7 (CH3-SR), 96.3 (OdC-C-C-NHR),
123.0 (aryl-C), 126.5 (aryl-C), 126.9 (aryl-C), 129.7 (aryl-C), 132.8
(aryl-C), 135.8 (NHR-C-C-S-CH3), 146.3 (NHR-C-CdO),
180.4 (OdC-C-NHR).
3
NMR (400 MHz, CD3CN): δ 1.07 (d, JH-H = 6.9 Hz, 6H,
CH(CH3)2), 1.15 (d, 3JH-H = 6.9 Hz, 6H, CH(CH3)2), 1.82 (s,
6H, CH3), 2.58 (s, 6H, SCH3), 2.91 (sept, 3JH-H = 6.8 Hz, 2H,
CH(CH3)2), 4.78 (s, 2H, quinone-H), 5.01 (d, 3JH-H = 5.8 Hz,
2H, arene-H), 5.39 (d, 3JH-H = 6.0 Hz, 2H, arene-H), 5.52 (d,
[{Cl(η6-Cym)Ru}2(μ-L-2H1)] (1). Ru2(Cym)2Cl4 (80 mg, 0.13
mmol) and the ligand L1 (36.8 mg, 0.13 mmol) were dissolved in
CH2Cl2 (30 mL) under an argon atmosphere. NEt3 (1.0 mL) was
added, and the solution was stirred overnight at room tempera-
ture. The solution was concentrated, and the product was
precipitated by the addition of hexane. The compound was
filtered, washed with hexane, and dried in vacuo. The compound
was obtained as a reddish-purple solid (92 mg, 86%). Anal.
Calcd for C33H34Cl2F3NO3Ru2: C, 48.18; H, 4.17; N, 1.70.
Found: C, 47.86; H, 4.05; N, 1.66. MS (ESI) Calcd for C33H34-
ClF3NO3Ru2 ([M - Cl-]þ): m/z 788.03. Found: 788.03. 1H
3
3JH-H = 5.9 Hz, 2H, arene-H), 5.55 (d, JH-H = 6.0 Hz, 2H,
arene-H), 7.22 (t, 3JH-H = 6.9 Hz, 2H, aryl-H), 7.30 (d, 3JH-H
=
7.4 Hz, 2H, aryl-H), 7.36 (t, 3JH-H = 7.1 Hz, 2H, aryl-H), 7.44 (d,
3JH-H = 8.1 Hz, 2H, aryl-H).
[{(CH3CN)(η6-Cym)Ru}2(μ-L-2H1)][ClO4]2 (5[ClO4]2). Com-
plex 1 (24.7 mg, 0.03 mmol) and AgClO4 (12.0 mg, 0.06 mmol)
were dissolved in CH3CN (10 mL) under an argon atmosphere and
refluxed for 3 h. After cooling down to room temperature, the
solution was filtered and the filtrate collected. The solvent was
3
NMR (250 MHz, CDCl3): δ 1.09 (d, JH-H = 6.9 Hz, 3H,
CH(CH3)2), 1.16 (d, 3JH-H = 6.9 Hz, 3H, CH(CH3)2), 1.26 (d,